Sumitomo Dainippon Pharma Corporation

Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson’s disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry and Serotonin-agonist antianxiety drugs.
Technology:
Drug Discovery
Headquarters:
Osaka, Osaka, Japan
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
1997
Number Of Exists:
1
Employee Number:
5001-10000
Industry:
Pharma
Investor Type:
Undisclosed